Histone Deacetylase Inhibitors Market Report

China Histone Deacetylase Inhibitors Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：153
  • REPORT CODE：GMM1805992
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Histone Deacetylase Inhibitors industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Celleron Therapeutics

    • TetraLogic

    • MEI Pharma

    • Novartis

    • Curis

    • Chroma Therapeutics

    • Mirati Therapeutics

    • 4SC AG

    • CrystalGenomics

    • Repligen

    By Type:

    • Uncompetitive Inhibitors

    • Competitive Inhibitors

    • Mixed Inhibitors

    By Application:

    • Psychiatry and Neurology

    • Other Diseases

    • Inflammatory Diseases

    • Cancer Treatment

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Histone Deacetylase Inhibitors Market Overview 2018-2029

    • 1.1 China Histone Deacetylase Inhibitors Industry Development Overview

    • 1.2 China Histone Deacetylase Inhibitors Industry Development History

    • 1.3 China Histone Deacetylase Inhibitors Industry Market Size (2018-2029)

    • 1.4 China Histone Deacetylase Inhibitors Market Analysis by Type from Production Side

      • 1.4.1 China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Uncompetitive Inhibitors (2018-2029)

      • 1.4.2 China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Competitive Inhibitors (2018-2029)

      • 1.4.3 China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Mixed Inhibitors (2018-2029)

    • 1.5 China Histone Deacetylase Inhibitors Market Analysis by Application from Consumption End

      • 1.5.1 China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Psychiatry and Neurology (2018-2029)

      • 1.5.2 China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

      • 1.5.3 China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Inflammatory Diseases (2018-2029)

      • 1.5.4 China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Cancer Treatment (2018-2029)

    • 1.6 China Histone Deacetylase Inhibitors Market Analysis by Region

      • 1.6.1 North China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    Chapter 2 China Histone Deacetylase Inhibitors Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Histone Deacetylase Inhibitors Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Histone Deacetylase Inhibitors Market Status and Competition Analysis in 2023

      • 2.2.3 China Histone Deacetylase Inhibitors Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Histone Deacetylase Inhibitors Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Histone Deacetylase Inhibitors Industry Development

    Chapter 3 Histone Deacetylase InhibitorsIndustry Chain Analysis

    • 3.1 Histone Deacetylase Inhibitors Industry Chain

    • 3.2 Histone Deacetylase Inhibitors Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Histone Deacetylase Inhibitors Market

    • 3.3 Histone Deacetylase Inhibitors Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Histone Deacetylase Inhibitors Market

    Chapter 4 China Histone Deacetylase Inhibitors Market, by Type

    • 4.1 China Histone Deacetylase Inhibitors Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Histone Deacetylase Inhibitors Total Production Volume and Growth Rate from Production Side

    • 4.5 China Histone Deacetylase Inhibitors Production Volume and Growth Rate, by Type

      • 4.5.1 China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Uncompetitive Inhibitors

      • 4.5.2 China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Competitive Inhibitors

      • 4.5.3 China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Mixed Inhibitors

    Chapter 5 China Histone Deacetylase Inhibitors Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Histone Deacetylase Inhibitors Total Market Size and Growth Rate from Consumption End

    • 5.5 China Histone Deacetylase Inhibitors Market Size and Growth Rate, by Application

      • 5.5.1 China Histone Deacetylase Inhibitors Market Size and Growth Rate of Psychiatry and Neurology

      • 5.5.2 China Histone Deacetylase Inhibitors Market Size and Growth Rate of Other Diseases

      • 5.5.3 China Histone Deacetylase Inhibitors Market Size and Growth Rate of Inflammatory Diseases

      • 5.5.4 China Histone Deacetylase Inhibitors Market Size and Growth Rate of Cancer Treatment

    Chapter 6 China Histone Deacetylase Inhibitors Market, by Region

    • 6.1 China Histone Deacetylase Inhibitors Production Volume and Production Value, by Region

    • 6.2 China Histone Deacetylase Inhibitors Sales Volume and Sales Value, by Region

    Chapter 7 North China Histone Deacetylase Inhibitors Market Analysis

    • 7.1 North China Histone Deacetylase Inhibitors Market, by Type

    • 7.2 North China Histone Deacetylase Inhibitors Market, by Application

    Chapter 8 Central China Histone Deacetylase Inhibitors Market Analysis

    • 8.1 Central China Histone Deacetylase Inhibitors Market, by Type

    • 8.2 Central China Histone Deacetylase Inhibitors Market, by Application

    Chapter 9 South China Histone Deacetylase Inhibitors Market Analysis

    • 9.1 South China Histone Deacetylase Inhibitors Market, by Type

    • 9.2 South China Histone Deacetylase Inhibitors Market, by Application

    Chapter 10 East China Histone Deacetylase Inhibitors Market Analysis

    • 10.1 East China Histone Deacetylase Inhibitors Market, by Type

    • 10.2 East China Histone Deacetylase Inhibitors Market, by Application

    Chapter 11 Northeast China Histone Deacetylase Inhibitors Market Analysis

    • 11.1 Northeast China Histone Deacetylase Inhibitors Market, by Type

    • 11.2 Northeast China Histone Deacetylase Inhibitors Market, by Application

    Chapter 12 Southwest China Histone Deacetylase Inhibitors Market Analysis

    • 12.1 Southwest China Histone Deacetylase Inhibitors Market, by Type

    • 12.2 Southwest China Histone Deacetylase Inhibitors Market, by Application

    Chapter 13 Northwest China Histone Deacetylase Inhibitors Market Analysis

    • 13.1 Northwest China Histone Deacetylase Inhibitors Market, by Type

    • 13.2 Northwest China Histone Deacetylase Inhibitors Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Celleron Therapeutics

        • 14.1.1 Celleron Therapeutics Company Profile

        • 14.1.2 Celleron Therapeutics Histone Deacetylase Inhibitors Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 TetraLogic

        • 14.2.1 TetraLogic Company Profile

        • 14.2.2 TetraLogic Histone Deacetylase Inhibitors Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 MEI Pharma

        • 14.3.1 MEI Pharma Company Profile

        • 14.3.2 MEI Pharma Histone Deacetylase Inhibitors Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis

        • 14.4.1 Novartis Company Profile

        • 14.4.2 Novartis Histone Deacetylase Inhibitors Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Curis

        • 14.5.1 Curis Company Profile

        • 14.5.2 Curis Histone Deacetylase Inhibitors Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Chroma Therapeutics

        • 14.6.1 Chroma Therapeutics Company Profile

        • 14.6.2 Chroma Therapeutics Histone Deacetylase Inhibitors Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mirati Therapeutics

        • 14.7.1 Mirati Therapeutics Company Profile

        • 14.7.2 Mirati Therapeutics Histone Deacetylase Inhibitors Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 4SC AG

        • 14.8.1 4SC AG Company Profile

        • 14.8.2 4SC AG Histone Deacetylase Inhibitors Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 CrystalGenomics

        • 14.9.1 CrystalGenomics Company Profile

        • 14.9.2 CrystalGenomics Histone Deacetylase Inhibitors Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Repligen

        • 14.10.1 Repligen Company Profile

        • 14.10.2 Repligen Histone Deacetylase Inhibitors Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Histone Deacetylase Inhibitors Industry Research Conclusions

    • 15.2 Histone Deacetylase Inhibitors Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Histone Deacetylase Inhibitors Industry Market Size (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Uncompetitive Inhibitors (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Competitive Inhibitors (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Production Volume, Production Value and Growth Rate of Mixed Inhibitors (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Psychiatry and Neurology (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Other Diseases (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Inflammatory Diseases (2018-2029)

    • Figure China Histone Deacetylase Inhibitors Sales Volume, Sales Value and Growth Rate of Cancer Treatment (2018-2029)

    • Figure North China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Central China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure South China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure East China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Histone Deacetylase Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Histone Deacetylase Inhibitors Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Histone Deacetylase Inhibitors Market Share by Type in 2018

    • Figure China Histone Deacetylase Inhibitors Market Share by Type in 2023

    • Figure China Histone Deacetylase Inhibitors Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Uncompetitive Inhibitors (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Competitive Inhibitors (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Production Volume and Growth Rate of Mixed Inhibitors (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Market Share by Application in 2018

    • Figure China Histone Deacetylase Inhibitors Market Share by Application in 2023

    • Figure China Histone Deacetylase Inhibitors Total Market Size and Growth Rate from Consumption End

    • Figure China Histone Deacetylase Inhibitors Market Size and Growth Rate of Psychiatry and Neurology (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Market Size and Growth Rate of Other Diseases (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Market Size and Growth Rate of Inflammatory Diseases (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Market Size and Growth Rate of Cancer Treatment (2018-2023)

    • Table China Histone Deacetylase Inhibitors Production Volume by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Production Volume Share by Region (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Production Volume Share by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Production Value by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Production Value Share by Region (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Production Value Share by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Sales Volume by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Sales Volume Share by Region (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Sales Volume Share by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Sales Value by Region (2018-2023)

    • Table China Histone Deacetylase Inhibitors Sales Value Share by Region (2018-2023)

    • Figure China Histone Deacetylase Inhibitors Sales Value Share by Region (2018-2023)

    • Table North China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table North China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure North China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table North China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table North China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure North China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Central China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table Central China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Central China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table Central China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table Central China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Central China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table South China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table South China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure South China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table South China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table South China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure South China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table East China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table East China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure East China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table East China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table East China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure East China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northeast China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table Northeast China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northeast China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northeast China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table Northeast China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Southwest China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table Southwest China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Southwest China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table Southwest China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table Southwest China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northwest China Histone Deacetylase Inhibitors Production Volume by Type (2018-2023)

    • Table Northwest China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northwest China Histone Deacetylase Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northwest China Histone Deacetylase Inhibitors Sales Volume by Application (2018-2023)

    • Table Northwest China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Histone Deacetylase Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Celleron Therapeutics Company Profile

    • Table Celleron Therapeutics Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table TetraLogic Company Profile

    • Table TetraLogic Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table MEI Pharma Company Profile

    • Table MEI Pharma Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Curis Company Profile

    • Table Curis Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Chroma Therapeutics Company Profile

    • Table Chroma Therapeutics Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Mirati Therapeutics Company Profile

    • Table Mirati Therapeutics Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table 4SC AG Company Profile

    • Table 4SC AG Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table CrystalGenomics Company Profile

    • Table CrystalGenomics Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Repligen Company Profile

    • Table Repligen Histone Deacetylase Inhibitors Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US